Tomohiko Ohashi

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Erina Kumagai, Yohei Mano, Sachiyo Yoshio et al. · Scientific Reports · 2016 · 105 citations · Full text

Medicine, Pathobiology, Pathology +17

Ezetimibe for the treatment of non‐alcoholic fatty liver disease: A meta‐analysis

Yukiomi Nakade, Kenta Murotani, Tadahisa Inoue et al. · Hepatology Research · 2017 · 76 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Hirotaka Shoji, Sachiyo Yoshio, Yohei Mano et al. · Scientific Reports · 2016 · 64 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis

Yosui Tamaki, Yukiomi Nakade, Taeko Yamauchi et al. · Journal of Gastroenterology · 2012 · 56 citations

Medicine, Oncology, Pharmacology +12

Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction

Tadahisa Inoue, Mayu Ibusuki, Rena Kitano et al. · Endoscopy · 2020 · 46 citations

Medicine, Surgery, General Surgery +12